Stem Cells Spin S.A. (WSE:SCS)

Stem Cells Spin Statistics

Total Valuation

Stem Cells Spin has a market cap or net worth of PLN 11.57 million. The enterprise value is 11.68 million.

Market Cap	11.57M
Enterprise Value	11.68M

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Stem Cells Spin has 41.34 million shares outstanding.

Current Share Class	39.64M
Shares Outstanding	41.34M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	5.72%
Owned by Institutions (%)	n/a
Float	22.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	199.78
PB Ratio	1.71
P/TBV Ratio	1.72
P/FCF Ratio	n/a
P/OCF Ratio	3.60
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.79, with an EV/FCF ratio of -163.39.

EV / Earnings	-22.23
EV / Sales	201.57
EV / EBITDA	10.79
EV / EBIT	n/a
EV / FCF	-163.39

Financial Position

The company has a current ratio of 14.83, with a Debt / Equity ratio of 0.02.

Current Ratio	14.83
Quick Ratio	0.62
Debt / Equity	0.02
Debt / EBITDA	0.10
Debt / FCF	-1.46
Interest Coverage	-137.63

Financial Efficiency

Return on equity (ROE) is -7.47% and return on invested capital (ROIC) is -4.58%.

Return on Equity (ROE)	-7.47%
Return on Assets (ROA)	-2.73%
Return on Invested Capital (ROIC)	-4.58%
Return on Capital Employed (ROCE)	-4.92%
Revenue Per Employee	57,936
Profits Per Employee	-525,251
Employee Count	1
Asset Turnover	0.00
Inventory Turnover	0.01

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -11.05% in the last 52 weeks. The beta is 0.67, so Stem Cells Spin's price volatility has been lower than the market average.

Beta (5Y)	0.67
52-Week Price Change	-11.05%
50-Day Moving Average	0.22
200-Day Moving Average	0.21
Relative Strength Index (RSI)	57.09
Average Volume (20 Days)	49,752

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Stem Cells Spin had revenue of PLN 57,936 and -525,251 in losses. Loss per share was -0.01.

Revenue	57,936
Gross Profit	53,838
Operating Income	-521,462
Pretax Income	-525,251
Net Income	-525,251
EBITDA	1.08M
EBIT	-521,462
Loss Per Share	-0.01

Balance Sheet

The company has 495 in cash and 104,304 in debt, giving a net cash position of -103,809 or -0.00 per share.

Cash & Cash Equivalents	495
Total Debt	104,304
Net Cash	-103,809
Net Cash Per Share	-0.00
Equity (Book Value)	6.77M
Book Value Per Share	0.16
Working Capital	611,637

Cash Flow

In the last 12 months, operating cash flow was 3.22 million and capital expenditures -3.29 million, giving a free cash flow of -71,472.

Operating Cash Flow	3.22M
Capital Expenditures	-3.29M
Free Cash Flow	-71,472
FCF Per Share	-0.00

Margins

Gross Margin	92.93%
Operating Margin	-900.07%
Pretax Margin	-906.61%
Profit Margin	n/a
EBITDA Margin	1,867.69%
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Stem Cells Spin does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-4.54%
FCF Yield	-0.62%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Stem Cells Spin has an Altman Z-Score of 1.82 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.82
Piotroski F-Score	4